SCHEMBL319783

SCHEMBL319783

O=C1CCCSC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702146 0.81
Thiobutyrolactone SCHEMBL13480 0.69
Thiobutyrolactone SCHEMBL1021969 0.69
SCHEMBL4180598 0.65
SCHEMBL33935 0.61
SCHEMBL17971494 0.61 TRIM24 (0.54)
SCHEMBL289021 0.61
SCHEMBL1024355 0.61
SCHEMBL1026885 0.61
SCHEMBL6752722 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108431004-B Heterocyclic compounds 武田药品工业株式会社 2021-02-12 CN claimed
US-20180022746-A1 INDAZOLE AND AZAINDAZOLE SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY 2018-01-25 US claimed
WO-2016123629-A1 INDAZOLE AND AZAINDAZOLE SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY (US) 2016-08-04 WO claimed
US-8173638-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-08 US claimed
US-20100009964-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-14 US claimed
WO-2008064054-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-29 WO claimed
WO-2008031016-A2 HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-03-13 WO claimed
WO-2005122379-A9 ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY UNIV CALIFORNIA (US) 2006-03-09 WO claimed
WO-2005122379-A2 ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-22 WO claimed
EP-0192967-A1 Sulphurated derivatives of aromatic-aliphatic and aliphatic ketones as polymerisation photoinitiators FRATELLI LAMBERTI S.p.A. (IT) 1986-09-03 EP claimed
WO-2025233174-A1 BENZIMIDAZOLE DERIVATIVES AS CGAS INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-13 WO disclosed
WO-2025226510-A1 LPAR1 INHIBITORS ABBVIE INC. (US) 2025-10-30 WO disclosed
CN-221778864-U Heat insulating board for building interior decoration 南京兴华建筑设计研究院股份有限公司 2024-09-27 CN disclosed
CN-118284606-A Bicyclic amine derivatives as GABAA α5 receptor modulators 吉瑞工厂 2024-07-02 CN disclosed
CN-112805063-B Bicyclic derivatives as modulators of the GABAA A5 receptor 吉瑞工厂 2024-02-23 CN disclosed
WO-2000040561-A1 QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2000-07-13 WO disclosed
EP-1000051-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-17 EP disclosed
WO-1999006390-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed
US-5026740-A For transparent or pigmented mixtures FRATELLI LAMBERTI S.P.A. (IT) 1991-06-25 US disclosed
EP-0192967-A1 Sulphurated derivatives of aromatic-aliphatic and aliphatic ketones as polymerisation photoinitiators FRATELLI LAMBERTI S.p.A. (IT) 1986-09-03 EP disclosed